Tag Archives: caffeine

What dose of caffeine to use?

Posted on 9 September 2022 by Keith Barrington

The dose of caffeine that we used for the CAP trial was the dose that was being widely used at the time. It seemed to be a safe dose, that did not require serum concentration surveillance, but was not based … Continue reading →

Posted in Neonatal Research | Tagged , , , | Leave a comment

The CAP babies are now 11

Posted on 25 April 2017 by Keith Barrington

I was privileged to be part of the CAP trial group, a pivotal neonatal trial that showed improved Bayley scores and improved motor function at 18 to 21 months corrected age, among infants randomized before 10 days of age, with … Continue reading →

Posted in Neonatal Research | Tagged , , | 2 Comments

Caffeine protects the lungs

Posted on 7 June 2016 by Keith Barrington

From the CAP trial we know that caffeine administration leads to less bronchopulmonary dysplasia. The question is how? The mechanism could help to design other studies, or help in a decision about clinical use where the question hasn’t been directly … Continue reading →

Posted in Neonatal Research | Tagged , | 3 Comments